Skip to main content

Closed

PYXS: Pyxis Oncology, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin-619.6%

ROIC-173.4%

Financially safe

Stretched

Debt / equity0.58×

Interest coverage0.0×

Current ratio2.76×

Pyxis Oncology, Inc.

PYXSNASDAQ Global Select·USD·Closed

Pyxis Oncology, Inc.

PYXSNASDAQ·USD·Closed

$2.65

−7.67%

$2.65

−$0.22 (7.67%)

52W Range

37thpctl

Volume

0.77×avg

Mkt Cap

167.89MUSD

P/E

-2.0TTM

Div Yield

–ann

52W Range

37thpctl

Volume

0.77×avg

Market Cap

167.89MUSD

P/E Ratio

-2.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings